Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson's Disease

被引:12
|
作者
Zhou, Yongtao [1 ,4 ,5 ]
Su, Yusheng [2 ]
Xu, Weihua [3 ]
Wang, Wei [3 ]
Yao, Shukun [3 ,4 ]
机构
[1] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Nucl Med Dept, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Gastroenterol Dept Tradit Chinese Med, 2 Yinghua Dong East St, Beijing 100053, Peoples R China
[4] China Japan Friendship Hosp, Dept Gastroenterol, Beijing 100029, Peoples R China
[5] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobi, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
Constipation; Parkinson's disease; inflammation; dopamine; immunoglobulin; nigrostriatal system; ALZHEIMERS-DISEASE; SYMPTOMS; NEURODEGENERATION; DYSFUNCTION; POPULATION; PREVALENCE; ACTIVATION;
D O I
10.2174/1567202616666190618170103
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Recent studies suggest that not only is constipation a clinical marker of pre-motor phase in Parkinson's Disease (PD), but is also correlated with the duration and severity. Some reports indicated that inflammatory from gut dysbiosis might be involved in the pathogenesis of PD, but the correlation between them remains poorly understood. This study aims to investigate how the presence of constipation affects the dopamine level of nigrostriatal system and whether gastrointestinal (GI) inflammation is involved in the brain-gut axis. Methods: Clinical materials, serum inflammatory factors, and datum of dopamine level including 84 cases and 83 controls, were collected consecutively and randomly from November 1, 2017 to October 31, 2018. Dopamine levels of nigrostriatal system were detected by [F-18]-DTBZ radiotracer (F-18-AV-133). Data analysis was conducted by variance, covariance analysis, bicorrelation, partial correlation, chi-square analysis and logistic regression. Results: The mean age of cases was older than that of controls, and male predominance was also observed (P<0.05). The mean scores of Hoehn-Yahr and unified Parkinson's disease rating scale III (UPDRS-III) were of significantly different duration between two groups (P<0.05). The total dose of levodopa was not different between two groups (P>0.05). The dopamine levels of putamen and caudate nucleus, especially in the dorsal part of putamen, were significantly decreased in cases than that in controls (P<0.05). There were significant differences of complement 3 (C3) and complement 4 (C4) between cases and controls (P<0.05). Dopamine levels in putamen and caudate nucleus were negatively correlated with serum concentrations of immunoglobulin A (IgA), immunoglobulin G (IgG) and C3 in cases (P<0.05). But we did not observe similar negative correlations in controls (P>0.05). Conclusion: The presence of constipation may increase the severity of motor symptoms and decrease dopamine levels of nigrostriatal system in PD. Inflammatory factors may be involved in the brain-gut axis of PD.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 12 条
  • [1] Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease
    Marchionini, Deanna M.
    Lehrmann, Elin
    Chu, Yaping
    He, Bin
    Sortwell, Caryl E.
    Becker, Kevin G.
    Kordower, Jeffrey H.
    Collier, Timothy J.
    BRAIN RESEARCH, 2007, 1147 : 77 - 88
  • [2] Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
    Hou, Lijuan
    Chen, Wei
    Liu, Xiaoli
    Qiao, Decai
    Zhou, Fu-Ming
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [3] Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?
    Thiruchelvam, M
    Brockel, BJ
    Richfield, EK
    Baggs, RB
    Cory-Slechta, DA
    BRAIN RESEARCH, 2000, 873 (02) : 225 - 234
  • [4] Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera, Andrea
    Munoz, Patricia
    Steinbusch, Harry W. M.
    Segura-Aguilar, Juan
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (04): : 702 - 711
  • [5] Dopamine Synthesis in the Nigrostriatal Dopaminergic System in Patients at Risk of Developing Parkinson's Disease at the Prodromal Stage
    Blokhin, Victor
    Pavlova, Ekaterina N.
    Katunina, Elena A.
    Nodel, Marina R.
    Kataeva, Galina V.
    Moskalets, Elina R.
    Pronina, Tatiana S.
    Ugrumov, Michael V.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [6] Association of Posture Instability with Dopamine Drop of Nigrostriatal System and Hypometabolism of Cerebral Cortex in Parkinson's Disease
    Wang, Hongyan
    Li, Hong-Yu
    Guo, Xiuhai
    Zhou, Yongtao
    CURRENT NEUROVASCULAR RESEARCH, 2021, 18 (02) : 244 - 253
  • [7] Phenothiazine normalizes the NADH/NAD+ ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease
    Tapias, Victor
    McCoy, Jennifer L.
    Greenamyre, J. Timothy
    REDOX BIOLOGY, 2019, 24
  • [8] Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson's Disease as a Manifestation of Neurodegeneration and Neuroplasticity
    Kolacheva, Anna
    Alekperova, Leyla
    Pavlova, Ekaterina
    Bannikova, Alyona
    Ugrumov, Michael V.
    BRAIN SCIENCES, 2022, 12 (06)
  • [9] Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease
    Tseng, Kuan-Yin
    Kuo, Tung-Tai
    Wang, Vicki
    Huang, Eagle Yi-Kung
    Ma, Kuo-Hsing
    Olson, Lars
    Hoffer, Barry J.
    Chen, Yuan-Hao
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (05) : 1545 - 1565
  • [10] PROTECTIVE EFFECTS OF VALPROIC ACID ON THE NIGROSTRIATAL DOPAMINE SYSTEM IN A 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON'S DISEASE
    Kidd, S. K.
    Schneider, J. S.
    NEUROSCIENCE, 2011, 194 : 189 - 194